ESZOPICLONE

Product NDC: 71335-1662
Requested package NDC: 71335-1662-2
11-digit product format: 713351662
Labeler code: 71335
Product ID: 71335-1662_f74c884f-1ed8-41fe-bbea-b100636115ee
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ESZOPICLONE
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA208451
Marketing category: ANDA
Marketing start: 2016-09-15
Marketing end: 0000-00-00
Substance: ESZOPICLONE
Active strength: 2 mg/1
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	71335-1662	71335-1662-2	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A208451-001	ESZOPICLONE	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15
A208451-002	ESZOPICLONE	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15
A208451-003	ESZOPICLONE	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A208451-001	AB
A208451-002	AB
A208451-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208451-002	ESZOPICLONE	2MG	TABLET / ORAL	AB	2016-09-15	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208451-003	ESZOPICLONE	3MG	TABLET / ORAL	AB	2016-09-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208451-001	ESZOPICLONE	1MG	TABLET / ORAL	AB	2016-09-15	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A208451-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208451-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A208451-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208451-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208451-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A208451-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A208451-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208451-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A208451-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208451-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208451-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A208451-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208451-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208451-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A208451-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208451-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208451-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A208451-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208451-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208451-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A208451-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208451-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208451-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A208451-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208451-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208451-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A208451-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A208451-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A208451-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A208451-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208451-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208451-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A208451-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208451-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208451-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A208451-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208451-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208451-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A208451-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A208451-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f65008ed-f925-2246-581a-e6a3201df7e4	Product name	5	20250107

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
71335-1662-1	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-2	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-3	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-4	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-5	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-6	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-7	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004
71335-1662-8	These highlights do not include all the information needed to use ESZOPICLONE TABLETS safely and effectively. See full prescribing information for ESZOPICLONE TABLETS. ESZOPICLONE tablets, for oral use, CIV Initial U.S. Approval: 2004

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
71335-1662-1	ESZOPICLONE	30 in 1 BOTTLE	TABLET, FILM COATED	30	2
71335-1662-2	ESZOPICLONE	60 in 1 BOTTLE	TABLET, FILM COATED	60	2
71335-1662-3	ESZOPICLONE	90 in 1 BOTTLE	TABLET, FILM COATED	90	2
71335-1662-4	ESZOPICLONE	120 in 1 BOTTLE	TABLET, FILM COATED	120	2
71335-1662-5	ESZOPICLONE	20 in 1 BOTTLE	TABLET, FILM COATED	20	2
71335-1662-6	ESZOPICLONE	100 in 1 BOTTLE	TABLET, FILM COATED	100	2
71335-1662-7	ESZOPICLONE	28 in 1 BOTTLE	TABLET, FILM COATED	28	2
71335-1662-8	ESZOPICLONE	10 in 1 BOTTLE	TABLET, FILM COATED	10	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71335-1662	ESZOPICLONE TABLET, FILM COATED [BRYANT RANCH PREPACK]	2	Legacy NDC, 8 package rows	20220205_f74c884f-1ed8-41fe-bbea-b100636115ee.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ESZOPICLONE	ESZOPICLONE	Preferred Pharmaceuticals, Inc.	45558f0a-83f1-49b9-ab18-f436c0be9677	2026-04-13	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	REMEDYREPACK INC.	7df922bc-5750-4259-906f-64f960c38d5f	2026-01-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	A-S Medication Solutions	57a8450c-59ee-4c96-bef4-308fa7b97d1e	2025-11-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	A-S Medication Solutions	bfa767ce-340b-4d3a-a9c7-0043b6d7ff6e	2025-11-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	A-S Medication Solutions	e261bf7f-1b89-4393-8c48-4e72fc29192f	2025-11-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	A-S Medication Solutions	923cc646-f22a-4a26-88f7-a19fce016321	2025-11-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	PD-Rx Pharmaceuticals, Inc.	bb972d36-4b2c-45ae-8504-3a16d352dd8b	2025-10-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
Eszopiclone	ESZOPICLONE	Advanced Rx of Tennessee, LLC	af869866-0a11-1a05-e053-2a95a90acdb8	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
Eszopiclone	ESZOPICLONE	Advanced Rx of Tennessee, LLC	af86fca8-571e-0cac-e053-2a95a90ae402	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	Bryant Ranch Prepack	39b96725-2a01-4d9f-a56d-af7491b3b601	2023-11-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	Proficient Rx LP	2f4fa6e8-be82-4fb5-9a11-9ba8f557c027	2022-08-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	Proficient Rx LP	024f833e-c20c-46a2-971b-3f2a716b1678	2022-06-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	Aurobindo Pharma Limited	f18cc76f-82aa-4ad7-b8ce-5737733ee104	2021-12-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451
ESZOPICLONE	ESZOPICLONE	Proficient Rx LP	bad8fe65-73c1-4542-8050-720af889905a	2020-12-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 208451 application number: ANDA208451

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
UZX80K71OE	ESZOPICLONE	138729-47-2	ESZOPICLONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
485442	eszopiclone 2 MG Oral Tablet	PSN	f74c884f-1ed8-41fe-bbea-b100636115ee	2
485442	eszopiclone 2 MG Oral Tablet	SCD	f74c884f-1ed8-41fe-bbea-b100636115ee	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
71335-1662-2	71335166202	60 TABLET, FILM COATED in 1 BOTTLE (71335-1662-2)	2020-07-08	0000-00-00	No	No	Current